Pharmafile Logo

Lexington Health

Lexington Health is a dedicated practice within Lexington Communications with specialist knowledge of healthcare communications and engagement. Our team combines extensive expertise in health policy and campaigns as well as press and digital communication, backed by senior counselling skills honed in our role as strategic advisers to leading global corporations and organisations. Our clients include major blue-chip companies, trade unions, campaign and patient advocacy groups and charities. Lexington Health’s knowledge and experience in strategic communications, and our detailed understanding of the healthcare, biopharmaceutical and medical technologies landscape, enables us to assist clients in dealing with the difficult and complex issues facing their organisations. We understand the need for concise, consistent and coherent communications and engagement and help our clients to secure maximum coverage for their messages among policymakers, politicians, the media, patient groups, clinicians, the public and wider stakeholder groups. Lexington Health also works at an international level, supporting clients across the globe. We have coordinated various campaigns not only in Europe but have also coordinated projects spanning different continents.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Visions4Health

Visions4Health are market access experts and your gateway to local adoption at pace. Leveraging our lived experience, understanding of national and local healthcare systems, and insights generated by our stakeholder…

View Profile

Company Details

The Connection 198 High Holborn, London, WC1V 7BD

 Latest Content from PMHub 

NEW WEBINAR: Maximizing Speed-to-Outcome for Life Science Companies

Stop losing momentum to the "logistics lag." The most successful life science teams have moved beyond fragmented spreadsheets and isolated meetings into a unified orchestration engine. Learn the strategies that...

Insight gaps leave Biopharma vulnerable to patent cliff crisis, warns expert

Press Releases | April 1, 2026 | Nmblr

With unprecedented patent cliffs looming, putting an estimated $200 to $400 billion in annual global sales at risk , senior strategy consultant and Nmblr founder, Janice MacLennan, is issuing a...

From text to context: Helping patients see side effects clearly

Discover how thoughtful design, clear language, and structured visuals can transform overwhelming side effect information into accessible, actionable insights for patients in our latest Health Literacy series.

HRW Wins 2026 Artificial Intelligence Excellence Award in the Pharmaceutical Category

Healthcare Research Worldwide (HRW) has been named a winner in the 2026 Artificial Intelligence Excellence Awards in the Pharmaceutical category, recognizing its innovative use of AI to deliver real-world impact....

Amiculum reaffirms presence in Dundee with new office and continued academic partnership

Press Releases | March 26, 2026 | Amiculum

Amiculum is pleased to announce the relocation of its Dundee team to a new, state-of-the-art facility at the Dundee Life Sciences Innovation Hub, an environment designed to accelerate scientific progress...

GRACE COMMS acquisition of WORDBIRD creates a merger of two independent, strategic and creative healthcare agencies

We are delighted to announce that Grace Comms and Wordbird Limited, both healthcare brand comms agencies with a creative mission in healthcare and a passion for people, are coming together....

Leading with Heart: Why Vulnerability is a Force Multiplier

In a world that often prizes "macho" decisiveness, Dr. Lobna Salem (CMO at Viatris) and Dr. Amrit Ray (Board Chairman and former Pfizer executive) are advocating for a more human...

Cardiology Education in the Age of AI: Join Medscape at ACC 2026

  As medical knowledge now doubles every 73 days, the challenge for cardiology clinicians has shifted from finding information to mastering precision. At the American College of Cardiology (ACC) 65th...

Lucid Group Appoints Former Pfizer R&D Leader Rod MacKenzie, CMG, PhD, as Board Chair to Drive Next Phase of Global Growth and Innovation

Appointment marks a pivotal step in Lucid’s next phase of growth, strengthening its ability to translate complex science into real-world impact. Lucid’s US Medical Affairs division unveils new proprietary insights...